10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

MERCK & CO., INC.

Ticker: MRK   Fiscal Year: 2013

Consolidated Statement of Income

Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014)

(In Millions, except shares in actual)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2013Dec 31, 2012Dec 31, 2011
Sales
$
44,033
47,26748,047
Costs, Expenses and Other
Materials and production16,95416,44616,871
Marketing and administrative11,91112,77613,733
Research and development7,5038,1688,467
Restructuring costs1,7096641,306
Equity income from affiliates(404)(642)(610)
Other (income) expense, net8151,116946
Total Costs, Expenses and Other38,48838,52840,713
 
Income Before Taxes5,5458,7397,334
 
Taxes on Income1,0282,440942
Net Income4,5176,2996,392
 
Less: Net Income Attributable to Noncontrolling Interests113131120
Net Income Attributable to Merck & Co., Inc.4,4046,1686,272
 
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)1.492.032.04
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)1.472.002.02
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

MERCK & CO., INC.

Ticker: MRK   Fiscal Year: 2013

Consolidated Statement of Comprehensive Income

Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014)

(In Millions, except shares in actual)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income Attributable to Merck & Co., Inc.
$
4,404
6,1686,272
Other Comprehensive Income (Loss) Net of Taxes:
Net unrealized gain (loss) on derivatives, net of reclassifications229(101)(37)
Net unrealized (loss) gain on investments, net of reclassifications(19)52(10)
Benefit plan net gain (loss) and prior service cost (credit), net of amortization2,758(1,321)(303)
Cumulative translation adjustment(483)(180)434
Other comprehensive income (loss), net of taxes2,485(1,550)84
 
Comprehensive Income Attributable to Merck & Co., Inc.6,8894,6186,356
 
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

MERCK & CO., INC.

Ticker: MRK   Fiscal Year: 2013

Consolidated Statement of Cash Flows

Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014)

(In Millions, except shares in actual)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2013Dec 31, 2012Dec 31, 2011
Cash Flows from Operating Activities
Net income
$
4,517
6,2996,392
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization6,9886,9787,427
Intangible asset impairment charges765200705
Gain on disposition of interest in equity method investment00(136)
Equity income from affiliates(404)(642)(610)
Dividends and distributions from equity affiliates237291216
Deferred income taxes(330)669(1,537)
Share-based compensation276335369
Other39928323
Net changes in assets and liabilities:
Accounts receivable436349(1,168)
Inventories(365)(482)(678)
Trade accounts payable522(302)182
Accrued and other current liabilities(397)(717)1,444
Income taxes payable(1,421)(34)(277)
Noncurrent liabilities(132)(1,747)(7)
Other563(1,203)(262)
Net Cash Provided by Operating Activities11,65410,02212,383
 
Cash Flows from Investing Activities
Capital expenditures(1,548)(1,954)(1,723)
Purchases of securities and other investments(17,991)(12,841)(7,325)
Proceeds from sales of securities and other investments16,2987,7836,149
Proceeds from sale of interest in equity method investment00175
Acquisitions of businesses, net of cash acquired(246)0(373)
Dispositions of businesses, net of cash divested460323
Cash inflows (outflows) from net investment hedges35039(86)
Other(57)168(30)
Net Cash Used in Investing Activities(3,148)(6,805)(2,890)
 
Cash Flows from Financing Activities
Net change in short-term borrowings(159)6241,076
Payments on debt(1,775)(22)(1,547)
Proceeds from issuance of debt6,4672,5620
Purchases of treasury stock(6,516)(2,591)(1,921)
Dividends paid to stockholders(5,157)(5,116)(4,691)
Other dividends paid(120)(120)(120)
Proceeds from exercise of stock options1,2101,310321
Other6086(22)
Net Cash Used in Financing Activities(5,990)(3,267)(6,904)
 
Effect of Exchange Rate Changes on Cash and Cash Equivalents(346)(30)42
Net Increase (Decrease) in Cash and Cash Equivalents2,170(80)2,631
 
Cash and Cash Equivalents at Beginning of Year13,45113,531
Cash and Cash Equivalents at End of Year15,62113,45113,531
 
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

MERCK & CO., INC.

Ticker: MRK   Fiscal Year: 2013

Consolidated Balance Sheet

Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014)

(In Millions, except shares in actual)
 As ofAs of
 Dec 31, 2013Dec 31, 2012
Assets
Current Assets
Cash and cash equivalents
$
15,621
13,451
Short-term investments1,8652,690
Accounts receivable (net of allowance for doubtful accounts of $146 in 2013 and $163 in 2012) (excludes accounts receivable of $275 in 2013 and $473 in 2012 classified in Other assets - see Note 5)7,1847,672
Inventories (excludes inventories of $1,704 in 2013 and $1,606 in 2012 classified in Other assets - see Note 6)6,2266,535
Deferred income taxes and other current assets4,7894,509
Total current assets35,68534,857
 
Investments9,7707,305
Property, Plant and Equipment (at cost)
Land550591
Buildings13,62713,196
Machinery, equipment and office furnishings17,10617,188
Construction in progress1,8112,440
Property, Plant and Equipment, Gross33,09433,415
 
Less: accumulated depreciation18,12117,385
Property, Plant and Equipment, Net, Total14,97316,030
 
Goodwill12,30112,134
Other Intangibles, Net23,80129,083
Other Assets9,1156,723
Total Assets105,645106,132
 
Liabilities and Equity
Current Liabilities
Loans payable and current portion of long-term debt4,5214,315
Trade accounts payable2,2741,753
Accrued and other current liabilities9,5019,737
Income taxes payable2511,200
Dividends payable1,3211,343
Total current liabilities17,86818,348
 
Long-Term Debt20,53916,254
Deferred Income Taxes6,7765,740
Other Noncurrent Liabilities8,13610,327
Merck & Co., Inc. Stockholders Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2013 and 20121,7881,788
Other paid-in capital40,50840,646
Retained earnings39,25739,985
Accumulated other comprehensive loss(2,197)(4,682)
Stockholders' equity before deduction for treasury stock79,35677,737
 
Less treasury stock, at cost: 649,576,808 shares in 2013 and 550,468,221 shares in 201229,59124,717
Total Merck & Co., Inc. stockholders equity49,76553,020
 
Noncontrolling Interests2,5612,443
Total equity52,32655,463
 
Total Liabilities and Equity105,645106,132
 
External Links 
MERCK & CO., INC. (MRK) Fiscal Year 2013
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip